Next-Generation Sequencing in Gynaecological Tumours: The Prognostic and Predictive Value of the Most Common Mutations Found in Ovarian, Endometrial, and Cervical Tumours: Literature Review and the University Medical Centre Utrecht Next-Generation Sequencing Data-Reference-Cited by-同舟云学术

Next-Generation Sequencing in Gynaecological Tumours: The Prognostic and Predictive Value of the Most Common Mutations Found in Ovarian, Endometrial, and Cervical Tumours: Literature Review and the University Medical Centre Utrecht Next-Generation Sequencing Data

Published:2017 Issue:6 Volume:84 Page:339-350
ISSN:1015-2008
Container-title:Pathobiology
language:en
Short-container-title:Pathobiology

Author:

van Winkel Eline,de Leng Wendy W.J.,Witteveen Petronella O.,Jonges Trudy,Willems Stefan M.,Langenberg Marlies H.G.

Publisher

S. Karger AG

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Reference42 articles.

1. De Roock W, Claes B, Bernasconi D, De Schutter J, Biesmans B, Fountzilas G, Kalogeras KT, Kotoula V, Papamichael D, Laurent-Puig P, Penault-Llorca F, Rougier P, Vincenzi B, Santini D, Tonini G, Cappuzzo F, Frattini M, Molinari F, Saletti P, De Dosso S, Martini M, Bardelli A, Siena S, Sartore-Bianchi A, Tabernero J, Macarulla T, Di Fiore F, Gangloff AO, Ciardiello F, Pfeiffer P, Qvortrup C, Hansen TP, Van Cutsem E, Piessevaux H, Lambrechts D, Delorenzi M, Tejpar S: Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol 2010; 11: 753–762.

2. Uji K, Naoi Y, Kagara N, Shimoda M, Shimomura A, Maruyama N, Shimazu K, Kim SJ, Noguchi S: Significance of TP53 mutations determined by next-generation “deep” sequencing in prognosis of estrogen receptor-positive breast cancer. Cancer Lett 2014; 342: 19–26.

3. Wheler J, Yelensky R, Falchook G, Kim KB, Hwu P, Tsimberidou AM, Stephens PJ, Hong D, Cronin MT, Kurzrock R: Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance. BMC Cancer 2015; 15: 61.

4. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A: Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.

5. Ford CE, Henry C, Llamosas E, Djordjevic A, Hacker N: Wnt signalling in gynaecological cancers: a future target for personalised medicine? Gynecol Oncol 2016; 140: 345–351.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic determinants in advanced endometrial cancer patients with sustained response to hormonal therapy- case series and review of literature;Frontiers in Oncology;2023-07-03

2. The role of biomarkers in endometrial cancer and hyperplasia: a literature review;Acta Oncologica;2019-01-07